Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 5 institutions in 1 country.
Daria V VasinaN.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.ORCID 0000-0003-1965-0700
Nataliia P AntonovaN.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
Aleksei M VorobevG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Aleksei I LaishevtsevFederal State Budget Scientific Institution "Federal Scientific Centre VIEV" (FSC VIEV), 117218 Moscow, Russia.ORCID 0000-0002-5050-2274
Andrei V KapustinFederal State Budget Scientific Institution "Federal Scientific Centre VIEV" (FSC VIEV), 117218 Moscow, Russia.ORCID 0000-0003-0136-2487
Eldar R ZulkarneevG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.ORCID 0000-0002-5920-8098
Svetlana S BochkarevaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Irina A KiselevaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Mariia N AnurovaDepartment of Pharmaceutical Technology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia.
Andrei V AleshkinG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Artem P TkachukN.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
Vladimir A GushchinN.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.ORCID 0000-0002-9397-3762
Gabrichevsky Institute of Epidemiology and Microbiology · RUMinistry of Health of the Russian Federation · RUAll-Russian Scientific Research Institute of Experimental Veterinary Sciences. Ya.R. Kovalenko · RULomonosov Moscow State University · RUSechenov University · RU
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Abscess formation is a common complication of severe life-threatening infections caused by obligate anaerobes.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by · full record | OpenQuestion